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Abstract 19 
Plasma hydroperoxides (HP) are widely accepted to be good indicators of oxidative stress. By 20 
means of the method proposed herein, which uses diphenyl-1-pyrenylphosphine (DPPP) as a 21 
fluorescent probe, all types of plasma HP were determined. The detection and quantification 22 
limits of the method were 0.08 and 0.25 nmols of cumene hydroperoxide (CHP) equivalents 23 
in 40 µL of plasma, respectively. The method is satisfactory in terms of precision (5.3% for 24 
14.5 µM CHP eq.; n=8) and the recoveries were 91% and 92% after standard additions of 26 25 
and 52 µM of CHP, respectively. The selectivity of the proposed method is higher than 96%. 26 
Moreover, optimization of the reaction conditions and the addition of 27 
ethylenediaminetetraacetic acid (EDTA) disodium salt and 2,6-di-tert-butyl-4-methylphenol 28 
(BHT) prevented the formation of HP artifacts during the analysis. Therefore, the proposed 29 
method is useful for simple and quantitative determination of total plasma HP. 30 
31 
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33 
Introduction 34 
Oxidative stress plays an important role in the development of many pathologies, including 35 
cancer [1, 2], cardiovascular [3, 4] and neurodegenerative diseases as well as other 36 
physiological processes such as ageing [5, 6]. Among the different methods used for the 37 
assessment of oxidative stress, the determination of lipid oxidation products in plasma has 38 
been widely accepted as a good indicator of oxidative imbalance [7]. However, there is 39 
growing evidence that proteins are also a major target of reactive oxygen species, and the 40 
resulting oxidative damage can lead to loss of their biological function. Furthermore, some 41 
protein oxidation products are good biomarkers to predict neurological disorders and age-42 
related diseases [6, 8]. Therefore, due to the biological relevance of oxidative damage 43 
regardless of its lipid or protein origin, the overall measurement of oxidation products by 44 
means of accurate and simple methods is of interest. 45 
Routine analysis techniques to estimate oxidative stress in biological samples include 46 
iodometric assays [9], spectrophotometric determination of conjugated dienes [7, 10], 47 
determination of thiobarbituric acid reactive substances values [11] and measurement of 48 
carbonyl content [12]. However, these methods are usually criticized for their lack of 49 
sensitivity and/or specificity. More sensitive methods, such as determination of 50 
hydroperoxides HP using luminal chemiluminescence [13] or HP activation of cycloxygenase 51 
[14] have also been proposed. However, the application of these methods is sometimes 52 
limited because they are often complex and require sophisticated instrumentation [13]. 53 
Alternatively, plasma lipid and protein HP can be determined by the formation of colored 54 
metal complexes with thiocyanate or xylenol orange. These methods are satisfactory in terms 55 
of sensitivity and simplicity [15, 16], but the procedures are subject to interference caused by 56 
chelators, ferric iron, some redox compounds or the presence of other chromophores. The 57 
ferrous oxidation-xylenol orange (FOX) method is commonly used for all kinds of biological 58 
sample, but plasma samples contain many compounds that can react with the dye and thus 59 
interfere with determination. Hence, it is common to use specific reducing agents for HP to 60 
discriminate the background signal from authentic HP [16, 17] . 61 
However, DPPP is a non-fluorescent molecule that specifically reacts with HP, forming DPPP 62 
oxide which then emits fluorescence at 380 nm (excitation wavelength 353 nm). In fact, the 63 
use of DPPP has been proven to allow selective and very sensitive determination of lipid HP 64 
in biological samples using flow injection and HPLC post-column methods [18, 19]. In 65 
addition, it has recently been reported that lipid and protein HP can be determined by this 66 
fluorescent probe using simple batch methods [20].  67 
The aim of this study was to set up and validate a modified version of this method based on 68 
the DPPP fluorescent probe for simple, sensitive and selective determination of total lipid and 69 
protein HP in plasma due to their clinical relevance as biomarkers of oxidative stress. 70 
71 
Material and methods 72 
Materials 73 
EDTA disodium salt solution, BHT, phosphate-buffer saline (PBS; 0.01M, pH=7.4), 74 
guanidine hydrochloride (GdnHCl), 80% CHP and triphenylphosphine (TPP) were purchased 75 
from Sigma Chemical Co. (St. Louis, MO, USA). Dipheny-1-pyrenylphosphine was 76 
purchased from Cayman Chemical Co. (Ann Arbor, Michigan, USA). Methanol and n-77 
butanol were of HPLC grade from Panreac (Barcelona, Spain). Bidistilled water was obtained 78 
using a Milli-Q® Gradient System (Millipore Co., Billerica, MA, USA). Positive displacement 79 
pipettes were used throughout the study.  80 
81 
Final procedure for determination of total plasma hydroperoxides 82 
The entire procedure was conducted under subdued light conditions and 1.5-mL microtubes 83 
with safe-lock were used to avoid evaporation.  First, 40 µL of plasma was mixed with 160 84 
µL of a solution which contained 0.125% EDTA and 6M GdnHCl in PBS. Then, 100 µL of 4 85 
mM BHT in methanol was immediately added. After vortexing for 1 min, 100 µL of 400 µM 86 
DPPP and 4 mM BHT in butanol were added and samples were vortexed again for 1 min. 87 
These solutions were extemporaneously prepared. The final concentrations of EDTA, BHT 88 
and DPPP were 0.05%, 2 mM and 100 µM, respectively. The head-space of the microtubes 89 
was flushed with nitrogen, immediately closed and then samples were incubated at 40ºC for 90 
3h under constant agitation. The reaction was stopped by placing the samples in an ice bath 91 
for 20 min. Then, 1 mL of 6M GdnHCl in PBS was added and samples were vortexed for 1 92 
min. One hundred µL of the resulting solution was thoroughly mixed for 2 min with 1 mL of 93 
butanol and samples were then centrifuged at 1500 x g for 10 min at 4ºC. One hundred µL of 94 
the supernatant was immediately transferred to 96-microwell plates and fluorescence was 95 
determined in a Fluostar Optima fluorimeter (BMG Labtech, Ortenberg, Germany) at 30ºC 96 
using the 360 ± 10 nm and 380 ± 10 nm fluorescence filters for excitation and emission, 97 
respectively. The signal was consecutively measured at intervals of 2 min for 10 min. Since 98 
the signal was observed to be stable, the average of the measurements was used for 99 
calculations.  100 
101 
Sample collection 102 
Blood samples were extracted by heart puncture from healthy Sprague-Dawley rats (6-8 103 
months old) fed with 2014 Teklad Global 14% Protein Rodent Maintenance Diet (Teklan 104 
Harlan, Madison, WI, USA). Samples were collected in heparin tubes as anticoagulant and 105 
immediately centrifuged at 1500 x g for 15 min at 4ºC for plasma separation. Plasma samples 106 
used for method development were pooled and stored in aliquots at -80ºC until analysis to 107 
avoid oxidation (unoxidized rat plasma, URP). Plasma samples used to determine the 108 
precision and recovery of the method were stored in the dark at 4ºC and analyzed within 24h 109 
after extraction (fresh URP). 110 
Hypercholesterolemic blood samples were obtained from eight Dunkin Harley guinea pigs (4 111 
weeks old) from Harlan Interfauna Ibérica (Barcelona, Spain). Animals were fed with 2040 112 
Teklad Global Diet for guinea pigs (Teklan Harlan, Madison, WI, USA) for one week of 113 
acclimation. Subsequently, blood samples from fasting animals were obtained from the 114 
saphenous vein and collected in heparin tubes. Animals were switched to a 115 
hypercholesterolemic experimental diet, the composition of which was as follows: protein 116 
18.8%, fat 17.1%, carbohydrates (non-fiber) 45.6%, cellulose 12.0%, cholesterol 0.25%, 117 
mineral mix 5.5% and vitamin mix 1.0%. The fat mix content of the diet was olive oil/palm-118 
kernel oil/safflower oil (1:2:1.8) and the carbohydrates were added as starch/sucrose (1:1.34). 119 
The mineral and vitamin mix was designed to meet all the nutritional requirements of guinea 120 
pigs [21]. After 4 weeks, blood samples from fasting animals were obtained from the 121 
saphenous vein and collected in heparin tubes. Plasma from initial and final blood samples 122 
was separated by centrifugation as described earlier and stored at -80ºC until analysis. In 123 
order to assess the hypercholesterolemic effect of the diet, plasma LDL cholesterol was 124 
determined fluorimetrically using enzymatic kits from BioVision, Inc. (Millpitas, CA). All the 125 
procedures were approved by the University of Barcelona’s Animal Care and Use Committee.  126 
127 
Preparation of oxidized plasma samples 128 
Oxidized rat plasma (ORP) samples were obtained by thermal oxidation of URP. A 129 
determined amount of URP was diluted with an equal volume of 6M GdnHCl in PBS and 130 
incubated at 80ºC for 1h under continuous magnetic stirring (500 rpm). ORP samples were 131 
used immediately for analysis. 132 
133 
Reaction kinetics  134 
Reaction time was studied by mixing 40 µL of diluted ORP samples (equivalent to 20 µL of 135 
plasma) with 160 µL of 6M GdnHCl in PBS containing 0.063% of EDTA (final concentration 136 
in the media of 0.025%), 100 µL of 2 mM BHT in methanol and 100 µL of 400 µM DPPP in 137 
2 mM BHT in butanol. Then, samples were incubated at 40, 50 and 60ºC and plasma HP 138 
determined as described earlier. All sample kinetics studies were conducted in triplicate. 139 
140 
Effect of antioxidant addition 141 
The influence of EDTA and BHT addition on the reaction was assessed by using a two-factor 142 
four-level (2x4) experimental design. First, 40 µL of ORP samples (equivalent to 20 µL of 143 
plasma) was diluted with 160 µL of 6M GdnHCl in PBS containing 0%, 0.0625%, 0.125% or 144 
0.25% of EDTA (final concentration in the media of 0%, 0.025%, 0.05%, 0.1% respectively). 145 
Then, 100 µL of 0, 2, 4 or 8 mM of BHT in methanol was added (final concentration in the 146 
media of 0, 0.5, 1, and 2 mM respectively). Samples were incubated at 40ºC for 3h and 147 
plasma HP determined as described earlier. The experiment was replicated 4 times. 148 
149 
Effect of sample amount  150 
The optimal amount of sample volume was studied by determining the HP of different 151 
amounts of ORP. Equivalent plasma volumes of 5, 10, 20, 30, 40 and 50 µL were made up to 152 
100 µL with 6M GdnHCl in PBS. Then, 100 µL 6M GdnHCl in PBS containing 0.2% of 153 
EDTA and 100 µL of 4 mM BHT in methanol were added. Finally, 100 µL of 400 µM DPPP 154 
in butanol containing 4 mM BHT were added and samples were then incubated for 3h at 155 
40ºC. Plasma HP was determined as described earlier. The final concentrations of EDTA, 156 
BHT and DPPP were 0.05%, 2 mM and 100 µM respectively. Studies were conducted in 157 
triplicate. 158 
159 
Selectivity of the method 160 
The selectivity of the method was assessed by adding TPP (reductant of organic HP) to 161 
plasma samples in a final concentration of 2 mM in the media. After mixing, samples were 162 
allowed to react for 1h and results were compared with the same plasma samples without 163 
added TPP. 164 
165 
Statistical analysis  166 
Data were analyzed by SPSS v.17 for Windows. Two-way ANOVA was used to determine 167 
the effect of addition of EDTA and BHT and their interaction. The exact nature of the 168 
differences between levels of addition was determined by Scheffé’s multirange test. 169 
Differences between initial and final values of plasma HP from guinea pigs were determined 170 
by paired-sample Student’s t-test. Differences were considered significant at P<0.05. 171 
172 
Results and discussion 173 
Reaction kinetics 174 
The fluorescence emitted by the DPPP probe over time at different incubation temperatures is 175 
shown in Figure 1. At 40ºC, fluorescence intensity reached a maximum at 2.5 h and then 176 
remained stable for at least 3.5 h of incubation. Conversely, the recorded fluorescence 177 
intensity at 50ºC and 60ºC was higher than that at 40ºC, and did not stabilize even after 210 178 
min. This different behavior was attributed to oxidation of the sample as a result of the 179 
incubation step. Determination of HP by the DPPP method is commonly conducted at 180 
reaction temperatures of 60ºC for 1 h or more [20], although higher temperatures can also be 181 
used for shorter times when using HPLC and flow injection analysis systems [22, 23].  182 
However, it remains questionable whether high temperatures could lead to the formation of 183 
HP artifacts during the incubation step, especially when a long incubation period is 184 
considered. Therefore, a reaction temperature of 40ºC was considered optimal for the 185 
determination of plasma HP as this temperature allows the HP to react with the DPPP and 186 
minimizes induced oxidation of the sample during the incubation step. Lower temperatures 187 
also minimize a potential underestimation that could be due to decomposition 188 
and/or volatilization of HP. Moreover, higher temperatures can lead to plasma protein 189 
denaturalization and further aggregation and precipitation, which could interfere with the 190 
analysis. In consequence, incubation of the sample for 3h at 40ºC was considered to be the 191 
optimum condition for determination of total plasma HP. In addition, flushing the head-space 192 
of the vial with nitrogen efficiently minimized oxidation during the incubation step, thus 193 
yielding a lower coefficient of variation within a run. It also resulted in slightly lower HP 194 
values, especially at high incubation temperatures (data not shown). 195 
196 
Effect of the antioxidant addition  197 
In order to further minimize the formation of HP artifacts, different doses of EDTA (0-0.1%) 198 
and BHT (0-2 mM) were added. It has previously been reported that neither the addition of 199 
BHT nor EDTA interferes in the development of fluorescence caused by oxidation of the 200 
DPPP [20, 24]. As shown in Table 1, results reveal that the amount of HP found varied 201 
depending on the final amount of EDTA and BHT in the reaction medium (P<0.01). Among 202 
the different concentrations of EDTA, the highest HP values were obtained when BHT was 203 
added at concentrations of 1 or 2 mM. This effect was explained by the protective effect of 204 
BHT on the oxidation of the DPPP probe in the blanks, thus causing a reduction in the 205 
background signal which in turn resulted in higher levels of relative fluorescence intensity. In 206 
contrast to BHT, EDTA did not significantly change blank signals, but it increased the 207 
fluorescence intensity of the samples. Since EDTA does not interfere, it is reasonable to 208 
assume that it exerted a protective effect on endogenous plasma HP by chelating transition 209 
metals, as these metals decompose HP into radicals [25]. Thus, their inactivation would lead 210 
to higher recoveries of endogenous plasma HP. The possibility of adding EDTA to avoid HP 211 
breakdown during analysis is a clear advantage over other methods such as the thiocyanate 212 
and FOX methods where EDTA interferes with the analysis. Among the different tested 213 
concentrations of EDTA, a final concentration of 0.05% was shown to be optimal, whereas a 214 
lower efficiency was observed at higher amounts (Table 1). It is probable that when 0.1% of 215 
EDTA was added, the high amount of solutes in the reaction media interfered with the 216 
reaction. Thus, a final concentration in the reaction media of 0.05% EDTA and 2 mM BHT 217 
was considered optimal to avoid oxidation of both the sample and the DPPP probe during the 218 
incubation step.  219 
220 
Effect of sample amount 221 
The effect of the matrix was studied by adding different volumes of ORP, equivalent to a 222 
range from 5 to 50 µL. The plot of sample volume versus response showed that the reaction 223 
was linear from 5 to 40 µL with an R2 of 0.998 (Figure 2). Within this range, the method 224 
afforded the same HP amounts with a coefficient of variation between different sample 225 
volumes of 5.8%. When the assay was repeated with URP, it was observed that volumes 226 
lower than 20 µL were below the limit of quantification of the method. However, the reaction 227 
was linear from 20 to 40 µL (R2=0.994) with a coefficient of variation between different 228 
sample volumes of 5.3 %. Hence, the maximum plasma volume is limited to 40 µL, probably 229 
because of the precipitation/denaturation of plasma proteins at higher concentrations. In fact, 230 
the precipitation of plasma proteins seems to be a critical aspect, and this was avoided with 231 
the appropriate solvent mixture. The presence of butanol significantly improves the response 232 
of HP after reaction with DPPP [20]. Hence, DPPP is dissolved in butanol, but since it is not 233 
miscible with aqueous solutions, the addition of methanol is critical to allow the reaction of 234 
DPPP with plasma HP. Due to the denaturation of plasma proteins by alcohols, whether 235 
methanol or butanol, a minimum amount of 50% of aqueous buffer is necessary. Likewise, 236 
the addition of solubilizing agents, such as GdnHCl or urea, proved to be useful to avoid 237 
protein precipitation in the selected solvent system. However, GdnHCl was more suitable than 238 
urea because the solubility of the latter is lower due to the presence of alcohols, thus limiting 239 
its addition at high concentrations. 240 
Given these considerations, 40 µL of plasma sample is, therefore, recommended as the sample 241 
volume for both URP and ORP samples because this amount is large enough to provide 242 
sufficient HP and lies within the linearity range of the method.  243 
244 
Linearity range and between days calibration 245 
The reaction was linear from 0.25 to 8 nmols of CHP eq. present in the reaction media (400 246 
µL; R2=0.997). The relative standard deviation within this concentration range was from 247 
16.8% to 2.04%. Since the linear range of the method depends on the concentration of DPPP 248 
in the medium, it could easily be increased by addition of higher amounts of DPPP (data not 249 
shown). Nevertheless, the addition of DPPP at 400 µM was considered optimal because 250 
higher amounts of HP are unlikely to be present in fresh plasma samples and the cost of the 251 
assay would increase with increased concentrations of the fluorescent probe.  252 
The slope of the calibration curve was constant between different days (relative standard 253 
deviation = 0.97 %, n=3) although the background signal was observed to vary slightly 254 
between assays. This was mainly attributed to oxidation of the DPPP probe, which can be 255 
partially minimized by improving its storage conditions. It is therefore recommended that 256 
independent aliquots of the probe are prepared and stored at -80ºC in the presence of nitrogen 257 
atmosphere and/or BHT. Moreover, it is recommended that a calibration curve is run daily 258 
with at least five standard concentrations in order to obtain reliable results. 259 
260 
Precision and recovery 261 
The precision of the method was assessed in fresh URP samples by determining total plasma 262 
HP amount in 8 aliquots of 40 µL (Table 2). The relative standard deviation for fresh URP 263 
samples was 5.3% (14.50 µM CHP eq.). The recovery of the method was studied by adding 264 
two standard amounts of CHP to plasma samples (final standard concentrations were 26 and 265 
52 µM). The recoveries of the method at these levels of addition were 91% and 92%, 266 
respectively. It is noteworthy to indicate that recoveries were high only when the amount of 267 
added GdnHCl was sufficient to maintain a homogenous reaction mixture. The resulting 268 
precision and recovery of the method were comparable to those previously reported for 269 
determination of lipid or protein HP by using the DPPP probe [20], and based on AOAC 270 
recommendations are satisfactory as well [26]. Therefore, the proposed method represents an 271 
alternative to the FOX method which is commonly used to measure HP in plasma [17]. The 272 
latter method is more simple but it has been reported to have a higher variability (relative 273 
standard deviation between 7-14%) and lower recoveries (about 77%) [16, 27, 28].    274 
275 
Sensitivity and selectivity of the method 276 
The limit of detection and quantification of the method was determined as described 277 
elsewhere [29]. Accordingly, the method allows the detection and quantification of amounts 278 
as low as 0.08 nmols and 0.25 nmols of CHP eq. in the reaction medium (400 µL containing 279 
40 µL of plasma). Thus, the limit of detection and the limit of quantification in plasma can be 280 
set at 2.0 and 6.3 µM of CHP eq., respectively. These limits are slightly higher than those 281 
determined by means of the same fluorescent probe to determine HP in isolated lipids and 282 
proteinaceous samples [20]. However, it should be noted that first, a much more complex 283 
matrix (plasma) was used in order to validate the present method and, second, this method 284 
allows a high-throughput sample analysis. In addition, the novelty of the method is that does 285 
not require sample preparation steps or separation techniques such as HPLC [19, 30]. 286 
Provided that TPP and its oxide have no fluorescence activity [18, 23], it can be used as a 287 
reductant of organic HP and, therefore, allows to evaluate the selectivity of the method [20]. 288 
The amount of HP found in fresh URP was 14.5 ± 0.8 µM CHP eq. After addition of TPP, the 289 
concentration found was below the limit of detection of the method, which implies that the 290 
background signal was lower than 4% and the method highly selective for organic HP. The 291 
same samples were analyzed by means of the commonly used version of the FOX method 292 
[16], which led to an overall HP concentration of 10.7 ± 0.37 µM CHP eq. However, after the 293 
addition of TPP to discriminate the background signal, this was shown to be approximately 294 
55%, meaning that the concentration of authentic HP determined by the FOX method was 4.9 295 
± 0.4 µM CHP eq. This concentration was in the range of results previously published for 296 
plasma from healthy humans [16, 31] and lower than the HP concentration determined by the 297 
present DPPP method. These reported concentrations of HP determined by means of the FOX 298 
method are close or slightly below the quantification limit of the proposed method. However, 299 
it is important to note that these concentrations are determined after the background signal 300 
subtraction, which is much higher than in the present method. Therefore, these reported low 301 
concentrations are not consequence of lower quantification limits, which are usually not 302 
reported for the FOX method. The selectivity of the proposed method is, therefore, a clear 303 
advantage.  304 
The methods to measure plasma HP show differences in precision, recovery and selectivity 305 
due, in part, to the diversity of plasma HP, their low stability and their easy formation of 306 
artifacts. Therefore, there is no methodological consensus on their determination and it is 307 
difficult to compare the results obtained in different studies [32, 33, 34]. The use of 308 
antioxidants as protective agents, the lack of extraction steps and the good recovery and 309 
selectivity of the method confirmed that the present method is accurate for measurement of 310 
total authentic HP. Moreover, the present method allows the determination not only of lipid 311 
HP but also HP of protein origin. Given these findings, it is not surprising to find higher 312 
levels of plasma HP when using the proposed method.  313 
314 
Performance of the method by using guinea pig plasma samples 315 
Guinea pig plasma samples were analyzed because this animal responds to dietary cholesterol 316 
in a similar manner to that of humans and, in contrast to other rodents, accumulates 317 
cholesterol in the arterial wall and develops atherosclerosis, thus rendering it a suitable model 318 
[35]. The results obtained for plasma samples from healthy and hypercholesterolemic guinea 319 
pigs confirmed this fact (Figure 3), as plasma LDL cholesterol levels were 16 ± 6.3 and 266 ± 320 
108 mg dL-1, respectively. Furthermore, oxidative stress is commonly associated with obesity 321 
and hypercholesterolemia [3, 36]. Using the proposed method, results for total HP from 322 
healthy guinea pigs fed a standard diet were 24.7 ± 2.2 µM of CHP eq., but after consumption 323 
of hypercholesterolemic diets plasma oxidation levels increased up to 31.0 ± 3.9 µM of CHP 324 
eq. (P=0.041). This represents an increase of about 25%, consistent with findings previously 325 
reported by Nourooz et al. [16]. 326 
327 
Conclusion 328 
The method developed for quantitative determination of total plasma HP was satisfactory in 329 
terms of simplicity, sensitivity, precision and selectivity. The method requires small amounts 330 
of sample and is not dependent on expensive equipment. A distinct advantage is that it omits 331 
previous extraction of plasma HP, which allows good recoveries and accurate determination 332 
of total HP rather than individual classes (i.e. lipid HP). In conclusion, the method offers a 333 
useful alternative for determination of plasma HP which is of particular interest for assessing 334 
oxidative stress.  335 
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FIGURE LEGENDS442 
443 
444 
Figure 1. Fluorescence intensity over time of oxidized rat plasma (ORP) samples incubated at different 445 
temperatures. Error bars represent the SD of the means (n=3). 446 
447 
Figure 2. Amount of hydroperoxides (nanomols of cumene hydroperoxide equivalents) found after incubation of 448 
different volumes of oxidized rat plasma for 3 h at 40ºC. Error bars represent the SD of the means (n=3). 449 
450 
Figure 3. Initial and final plasma hydroperoxide content in guinea pigs fed with hypercholesterolemic diets for 451 
28 days. Results are expressed in µM of cumene hydroperoxide equivalents. Error bars represent the SD of the 452 
means (n=6). Results were statistically different based on paired samples t-Student’s test (P=0.041).  453 
454 
Figure  1. Reaction kinetics at different temperatures. 455 
456 
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Figure 2: Effect of sample amount  460 
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Figure 3: Plasma hydroperoxides in guinea pigs 464 
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Table 1: Effect of antioxidant addition1467 
BHT 
0 mM  0.5 mM  1 mM  2 mM 
EDTA 0 % 1.06 ± 0.11 a, x 1.17 ± 0.10 a, x 1.40 ± 0.11 a, y 1.49 ± 0.02 a, y
 0.025% 1.42 ± 0.24 a, x 1.86 ± 0.17 b, y 2.05 ± 0.20 b, yz 2.35 ± 0.13 b, z
 0.05% 2.32 ± 0.10 b, x 2.48 ± 0.09 c, x 2.92 ± 0.09 c, x 3.06 ± 0.10 c, y
 0.1% 2.10 ± 0.04 b, x 2.24 ± 0.04 c, xy 2.29 ± 0.07 b, xy 2.34 ± 0.13 b, y
468 
1 Results expressed as means ± SD  in nmols of cumene hydroperoxide equivalents found in 20 µL aliquots of 469 
oxidized rat plasma after incubation at 40ºC for 3 hours. Results in the same column that do not share the same 470 
superscript (a, b or c) are significantly different based on Scheffé’s post hoc test (P<0.05) at different final 471 
concentrations of ethylenediaminetetraacetic acid (EDTA). Results in the same row that do not share the same 472 
superscript (x, y or z) are significantly different based on Scheffé’s post hoc test (P<0.05) at different final 473 
concentrations of 2,6-di-tert-butyl-4-methylphenol (BHT).474 
475 
Table 2. Relative standard deviation and recovery of hydroperoxides in fresh unoxidized 476 
rat plasma at two levels of cumene hydroperoxide (CHP) standard addition1477 
478 
479 
480 
481 
482 
1 n=8 for non-spiked fresh unoxidized rat samples and n=6 for spiked fresh normal rat samples.  483 
484 
485 
Levels of CHP standard addition 
0 µM 26  µM 52 µM
Concentration (µM CHP eq.) 14.50 37.97 62.4
RSD (%) 5.2 4.5 4.4
Recovery 90.5 92.3
Table 3. Abbreviation list 486 
Name Abbreviation 
2,6-di-tert-butyl-4-methylphenol  
Cumene hydroperoxide 
Diphenyl-1-pyrenylphosphine 
Ethylenediaminetetraacetic acid 
Ferrous oxidation-xylenol orange 
Guanidine hydrochloride  
Hydroperoxide 
Oxidized rat plasma 
Phosphate-buffer saline 
Triphenylphosphine 
Unoxidized rat plasma 
BHT 
CHP 
DPPP 
EDTA 
FOX 
GdnHCl 
HP 
ORP 
PBS  
TPP 
URP 
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